ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 140 filers reported holding ATARA BIOTHERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,733,575 | -8.8% | 2,522,686 | -0.8% | 0.00% | – |
Q2 2023 | $4,092,720 | -82.9% | 2,542,062 | -69.1% | 0.00% | -100.0% |
Q1 2023 | $23,888,672 | -52.4% | 8,237,473 | -46.2% | 0.00% | 0.0% |
Q4 2022 | $50,182,294 | +64.0% | 15,299,480 | +88.9% | 0.00% | -50.0% |
Q3 2022 | $30,608,000 | -36.8% | 8,097,353 | +30.1% | 0.00% | -33.3% |
Q2 2022 | $48,467,000 | -16.8% | 6,221,686 | -0.8% | 0.00% | 0.0% |
Q1 2022 | $58,282,000 | -14.5% | 6,273,617 | +45.1% | 0.00% | 0.0% |
Q4 2021 | $68,149,000 | +0.7% | 4,324,199 | +14.4% | 0.00% | -25.0% |
Q3 2021 | $67,678,000 | -0.4% | 3,780,897 | -13.5% | 0.00% | 0.0% |
Q2 2021 | $67,982,000 | +7.3% | 4,371,856 | -0.9% | 0.00% | 0.0% |
Q1 2021 | $63,367,000 | +8.2% | 4,412,774 | +47.9% | 0.00% | 0.0% |
Q4 2020 | $58,585,000 | +39.9% | 2,984,441 | -7.6% | 0.00% | +33.3% |
Q3 2020 | $41,874,000 | -12.0% | 3,231,040 | -1.1% | 0.00% | 0.0% |
Q2 2020 | $47,584,000 | +149.0% | 3,265,858 | +45.4% | 0.00% | +50.0% |
Q1 2020 | $19,111,000 | -47.3% | 2,245,710 | +2.1% | 0.00% | 0.0% |
Q4 2019 | $36,242,000 | -1.5% | 2,200,472 | -15.6% | 0.00% | -33.3% |
Q3 2019 | $36,801,000 | -21.0% | 2,606,271 | +12.5% | 0.00% | 0.0% |
Q2 2019 | $46,568,000 | -30.8% | 2,315,658 | +36.7% | 0.00% | -40.0% |
Q1 2019 | $67,338,000 | +15.1% | 1,694,026 | +0.6% | 0.01% | 0.0% |
Q4 2018 | $58,528,000 | -32.8% | 1,684,733 | -20.0% | 0.01% | -28.6% |
Q3 2018 | $87,070,000 | +12.8% | 2,105,716 | +0.2% | 0.01% | +16.7% |
Q2 2018 | $77,191,000 | -1.4% | 2,100,488 | +4.6% | 0.01% | -14.3% |
Q1 2018 | $78,317,000 | +875.1% | 2,008,067 | +352.4% | 0.01% | +600.0% |
Q4 2017 | $8,032,000 | +12.6% | 443,821 | +3.0% | 0.00% | 0.0% |
Q3 2017 | $7,136,000 | +20.2% | 431,050 | +1.7% | 0.00% | 0.0% |
Q2 2017 | $5,936,000 | -53.0% | 423,943 | -31.0% | 0.00% | 0.0% |
Q1 2017 | $12,634,000 | +48.2% | 614,785 | +2.4% | 0.00% | 0.0% |
Q4 2016 | $8,526,000 | +8.0% | 600,521 | +62.8% | 0.00% | 0.0% |
Q3 2016 | $7,894,000 | -1.3% | 368,980 | +3.9% | 0.00% | 0.0% |
Q2 2016 | $7,995,000 | +57.5% | 355,001 | +33.1% | 0.00% | 0.0% |
Q1 2016 | $5,077,000 | -68.0% | 266,752 | -55.7% | 0.00% | -50.0% |
Q4 2015 | $15,889,000 | +434.3% | 601,687 | +740.2% | 0.00% | – |
Q1 2015 | $2,974,000 | +193.0% | 71,612 | +88.6% | 0.00% | – |
Q4 2014 | $1,015,000 | – | 37,976 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
KPCB XV Associates, LLC | 1,876,650 | $29,182,000 | 13.03% |
Copernicus Capital Management, LLC | 50,000 | $778,000 | 12.27% |
Antipodean Advisors LLC | 1,000,000 | $15,550,000 | 4.28% |
BRIDGER MANAGEMENT, LLC | 1,325,188 | $20,607,000 | 1.92% |
Redmile Group, LLC | 6,449,577 | $100,291,000 | 1.48% |
MAVERICK CAPITAL LTD | 7,704,676 | $119,808,000 | 1.12% |
Baupost Group | 8,477,488 | $131,825,000 | 1.07% |
ACT CAPITAL MANAGEMENT, LLC | 116,900 | $1,818,000 | 0.93% |
Trellus Management Company, LLC | 73,056 | $1,136,000 | 0.78% |
PACIFIC HEIGHTS ASSET MANAGEMENT LLC | 525,000 | $8,164,000 | 0.75% |